Vascular Biogenics Ltd. - Ordinary Shares (VBLT) Social Stream

Vascular Biogenics Ltd. - Ordinary Shares (VBLT): $0.21

0.00 (-0.52%)

POWR Rating

Component Grades








Add VBLT to Watchlist
Sign Up

VASCULAR BIOGENICS LTD (VBLT) Price Targets From Analysts

Use the tables below to see what analysts covering VASCULAR BIOGENICS LTD think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-04-12 4 $7 $4 $5.875 $0.229 2465.5%
2022-05-17 5 $7 $4 $5.875 $0.229 2465.5%
2022-05-18 4 $7 $4 $5.5 $0.229 2301.75%
NA 3 $NA $NA $NA $0.229 NA%

The Trend in the Analyst Price Target

VBLT's average price target has moved up $0.5 over the prior 12 months.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

VBLT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations

Over the past 30 weeks, VBLT's average broker recommendation rating improved by 0.25.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VBLT as an investment opportunity.

  • VBLT has a greater number of analysts covering the stock than 97.34% of all US stocks.
  • VASCULAR BIOGENICS LTD's upside potential (average analyst target price relative to current price) is greater than 494.83% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, VASCULAR BIOGENICS LTD's average analyst price target is greater than 45.8% of them.
  • In the context of stocks in the micro market cap category, VASCULAR BIOGENICS LTD's variance in analysts' estimates is lower than -173.1% of them.

In the Pharmaceutical Products industry, CANF, BLRX, and GLMD are the three stocks most similar to VASCULAR BIOGENICS LTD regarding the price target and analyst recommendation information presented here.

Is VBLT a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!